About Us
Our Vision
Our Vision
Our Vision
Need for cleaner
chemical production
Need for cleaner
chemical production
Need for cleaner
chemical production
As the world’s population grows and resources are in greater demand than ever before, an alternative to outdated, pollution-producing chemical manufacturing is required to meet humanity’s needs.
As the world’s population grows and resources are in greater demand than ever before, an alternative to outdated, pollution-producing chemical manufacturing is required to meet humanity’s needs.
Approach to
bioproduction
Approach to
bioproduction
Approach to
bioproduction
Today, bioproduction relies primarily on fermentation, which entails significant complexities, lengthy development time, and high capital costs. Enzymit is changing the paradigm with its cell-free enzymatic approach to manufacturing.
We are dedicated to making bioproduction faster, more cost-effective and environmentally friendly than traditional chemical manufacturing and fermentation-based processes.
Today, bioproduction relies primarily on fermentation, which entails significant complexities, lengthy development time, and high capital costs. Enzymit is changing the paradigm with its cell-free enzymatic approach to manufacturing.
We are dedicated to making bioproduction faster, more cost-effective and environmentally friendly than traditional chemical manufacturing and fermentation-based processes.
Revolution in
biomanufacturing
Revolution in
biomanufacturing
Revolution in
biomanufacturing
Coined the next industrial revolution, biomanufacturing has been talked about for decades but has yet to be fully realized.
Enzymit provides the missing technological link, developing tailor-made new-to-nature enzymes that can unlock any desired chemical reaction, at costs that rival existing technologies in an environmentally friendly manner.
Coined the next industrial revolution, biomanufacturing has been talked about for decades but has yet to be fully realized.
Enzymit provides the missing technological link, developing tailor-made new-to-nature enzymes that can unlock any desired chemical reaction, at costs that rival existing technologies in an environmentally friendly manner.
Designing the bio-molecular machines of tomorrow
Designing the bio-molecular machines of tomorrow
Designing the bio-molecular machines of tomorrow
Designing the bio-molecular machines of tomorrow
Designing the bio-molecular machines of tomorrow
Designing the bio-molecular machines of tomorrow
Meet Our team
Meet Our team
Founded in 2020 by alumni of the Weizmann Institute of Science, Enzymit’s team includes experts in computational protein design, synthetic biology, generative Al, bioengineering, molecular biology and other specialties.
Leadership Team
Board
Advisory Board
Team
Gideon Lapidoth
CEO
Dror Baran
COO
Dror is an expert in synthetic biology and protein engineering, co-developer of Enzymit's core technology, with 10+ years of biotech experience. He specializes in antibody engineering, molecular biology, NGS, and biochemistry.
Dror holds a Master’s from the Weizmann Institute and a Bachelor’s in Biology from Ben Gurion University.
Itay Levin
VP R&D
Itay is a scientific leader with 16+ years of expertise in molecular biology, biochemistry, and protein engineering.
He held roles at biotech startups, served as Senior Scientific Director at Biolojic Design, earned a PhD from Tel Aviv University, and completed postdoctoral research at the University of Washington.
Nelli Morgulchik
Chief Of Staff
Nelli is a strategy and business development expert in biotech and healthcare, with experience spanning venture capital, venture building, and startup advisory across the UK, Europe, Israel, and the US. She previously was an investor at Hummingbird Ventures and led venture-building programmes with Pioneer Group.
She also co-founded and operates future.bio, a global techbio community, and holds an MRes in Drug Discovery and Development from Imperial College London and an MA in Natural Sciences from the University of Cambridge.
Leadership Team
Board
Advisory Board
Team
Gideon Lapidoth
CEO
Dror Baran
COO
Dror is an expert in synthetic biology and protein engineering, co-developer of Enzymit's core technology, with 10+ years of biotech experience. He specializes in antibody engineering, molecular biology, NGS, and biochemistry.
Dror holds a Master’s from the Weizmann Institute and a Bachelor’s in Biology from Ben Gurion University.
Itay Levin
VP R&D
Itay is a scientific leader with 16+ years of expertise in molecular biology, biochemistry, and protein engineering.
He held roles at biotech startups, served as Senior Scientific Director at Biolojic Design, earned a PhD from Tel Aviv University, and completed postdoctoral research at the University of Washington.
Nelli Morgulchik
Chief Of Staff
Nelli is a strategy and business development expert in biotech and healthcare, with experience spanning venture capital, venture building, and startup advisory across the UK, Europe, Israel, and the US. She previously was an investor at Hummingbird Ventures and led venture-building programmes with Pioneer Group.
She also co-founded and operates future.bio, a global techbio community, and holds an MRes in Drug Discovery and Development from Imperial College London and an MA in Natural Sciences from the University of Cambridge.
Todd Kenworth
Head of Hyaluronic Acid Business Development
Dotan Omer
Head of Biomanufacturing
Gideon Lapidoth
CEO
Dror Baran
COO
Itay Levin
VP R&D
Lior Zimmerman
Head of AI
Veronica Reiss
Lab Manager
Dotan Omer
Head of Biomanufacturing
Nelli Morgulchik
Chief Of Staff
Todd Kenworth
Head of Hyaluronic Acid Business Development
Leadership Team
Board
Advisory Board
Team
Our Investors
Our
Investors
Valuable Partnerships
Join Us
Join Us
Be part of a revolutionary team
Be part of a revolutionary team